ARGLU1-DT and renal carcinoma: The results showed that the expressions of RNF139-AS1, SRD5A3-AS1, LINC01094, USP30-AS1, LACTB2-AS1, and LINC01355 were elevated in renal carcinoma cells, and the expressions of RAP2C-AS1 and LINC00551 were reduced in renal carcinoma cells compared with normal renal proximal convoluted tubule cells (Figure 10).